Radionecrosis after stereotactic radiotherapy for brain metastases
暂无分享,去创建一个
G Vogin | N. Reyns | P. Metellus | F. Dhermain | É. Le Rhun | E Le Rhun | F Dhermain | N Reyns | P Metellus | G. Vogin | E. Rhun
[1] Y. Yamada,et al. Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment. , 2015, International journal of radiation oncology, biology, physics.
[2] C. Kufta,et al. Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies. , 1987, AJR. American journal of roentgenology.
[3] Y. Yoshii. Pathological review of late cerebral radionecrosis , 2008, Brain Tumor Pathology.
[4] A. Porter,et al. Hyperbaric oxygen therapy for radiation‐induced brain injury in children , 1997, Cancer.
[5] Chi-Ming Chan,et al. Acute Hemorrhage in Late Radiation Necrosis of the Temporal Lobe: Report of Five Cases and Review of The Literature , 2004, Journal of Neuro-Oncology.
[6] N. Lin,et al. Salvage stereotactic radiosurgery for breast cancer brain metastases , 2012, Cancer.
[7] D. Kondziolka,et al. Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: The Patients’ Perspective Regarding Complications , 2005, American journal of clinical oncology.
[8] P. Brown,et al. Radiosurgery to the postoperative surgical cavity: who needs evidence? , 2012, International journal of radiation oncology, biology, physics.
[9] J. Knisely,et al. Management of brain metastases: surgery, radiation, or both? , 2012, Hematology/oncology clinics of North America.
[10] L. Trodella,et al. Fractionated stereotactic radiosurgery for patients with brain metastases , 2014, Journal of Neuro-Oncology.
[11] N. Nonoguchi,et al. Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET. , 2013, Japanese journal of clinical oncology.
[12] D. Kondziolka,et al. Bevacizumab for refractory adverse radiation effects after stereotactic radiosurgery , 2013, Journal of Neuro-Oncology.
[13] M. Mehta,et al. Radiosurgery for patients with brain metastases: a multi-institutional analysis, stratified by the RTOG recursive partitioning analysis method. , 2001, International journal of radiation oncology, biology, physics.
[14] V. Esposito,et al. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases. , 2013, International journal of radiation oncology, biology, physics.
[15] N. Nonoguchi,et al. The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles , 2011, Journal of Neuro-Oncology.
[16] John Y. K. Lee,et al. Treatment of steroid refractory, Gamma Knife related radiation necrosis with bevacizumab: Case report and review of the literature , 2011, Clinical Neurology and Neurosurgery.
[17] Y. Yamada,et al. Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery. , 2013, Neuro-oncology.
[18] Douglas C. Miller,et al. Results of surgical resection for progression of brain metastases previously treated by gamma knife radiosurgery. , 2006, Neurosurgery.
[19] V. Levin,et al. Effect of bevacizumab on radiation necrosis of the brain. , 2007, International journal of radiation oncology, biology, physics.
[20] L. Palma,et al. Therapeutic strategy of late cerebral radionecrosis. A retrospective study of 21 cases. , 2010, Journal of neurosurgical sciences.
[21] Gene H. Barnett,et al. Laser Interstitial Thermal Therapy for Focal Cerebral Radiation Necrosis: A Case Report and Literature Review , 2012, Stereotactic and Functional Neurosurgery.
[22] H. Hoshi,et al. Significance of target location relative to the depth from the brain surface and high-dose irradiated volume in the development of brain radionecrosis after micromultileaf collimator-based stereotactic radiosurgery for brain metastases , 2012, Journal of Neuro-Oncology.
[23] K. Slavin,et al. An analysis of radiation necrosis of the central nervous system treated with bevacizumab , 2014, Journal of Neuro-Oncology.
[24] L D Lunsford,et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. , 1999, International journal of radiation oncology, biology, physics.
[25] C. Destrieux,et al. Radionecrosis of malignant glioma and cerebral metastasis: a diagnostic challenge in MRI. , 2014, Diagnostic and interventional imaging.
[26] Adam P Dicker,et al. Radiation dose-volume effects in the brain. , 2010, International journal of radiation oncology, biology, physics.
[27] M R Segal,et al. Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2008, American Journal of Neuroradiology.
[28] R. Müller,et al. Risk analysis of linear accelerator radiosurgery. , 1996, International journal of radiation oncology, biology, physics.
[29] R. Warnick,et al. Irradiated volume as a predictor of brain radionecrosis after linear accelerator stereotactic radiosurgery. , 2010, International journal of radiation oncology, biology, physics.
[30] H. Kooy,et al. Variables associated with the development of complications from radiosurgery of intracranial tumors. , 1991, International journal of radiation oncology, biology, physics.
[31] M. Glantz,et al. Neurologic complications of radiation therapy. , 2003, Neurologic clinics.
[32] D. Kondziolka,et al. Complications from arteriovenous malformation radiosurgery: multivariate analysis and risk modeling. , 1997, International journal of radiation oncology, biology, physics.
[33] Radiosurgery and brain tolerance: an analysis of neurodiagnostic imaging changes after gamma knife radiosurgery for arteriovenous malformations. , 1992, International journal of radiation oncology, biology, physics.
[34] Ann M. Peiffer,et al. Radiation-induced brain injury: A review , 2012, Front. Oncol..
[35] Samuel T Chao,et al. Challenges with the diagnosis and treatment of cerebral radiation necrosis. , 2013, International journal of radiation oncology, biology, physics.
[36] E. Wong,et al. Bevacizumab reverses cerebral radiation necrosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] P. Sundgren. MR Spectroscopy in Radiation Injury , 2009, American Journal of Neuroradiology.
[38] M. Mehta,et al. A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases. , 2002, International journal of radiation oncology, biology, physics.
[39] C. Matuschek,et al. Bevacizumab as a Treatment Option for Radiation-Induced Cerebral Necrosis , 2011, Strahlentherapie und Onkologie.
[40] M. Gilbert,et al. Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] Mark E Mullins,et al. Radiation necrosis versus glioma recurrence: conventional MR imaging clues to diagnosis. , 2005, AJNR. American journal of neuroradiology.
[42] F. Lang,et al. Resection of brain metastases previously treated with stereotactic radiosurgery. , 2005, Journal of neurosurgery.
[43] J. Beyene,et al. Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. , 2015, International journal of radiation oncology, biology, physics.
[44] J. Marks,et al. Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. , 1981, International journal of radiation oncology, biology, physics.
[45] A. Bozzao,et al. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis , 2011, Radiation oncology.
[46] T. Mikkelsen,et al. Treatment induced necrosis versus recurrent/progressing brain tumor: going beyond the boundaries of conventional morphologic imaging , 2010, Journal of Neuro-Oncology.
[47] D. Connolly,et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.
[48] B. Drayer,et al. Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? , 1998, AJNR. American journal of neuroradiology.
[49] G. Rao,et al. Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications. , 2009, Journal of neurosurgery.
[50] P Van Tassel,et al. Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment. , 2000, Radiology.
[51] Tarek Mekhail,et al. Adjuvant Whole-Brain Radiotherapy Versus Observation after Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study , 2011, Current oncology reports.
[52] F. Lang,et al. Radiosurgery in the treatment of brain metastases: critical review regarding complications , 2007, Neurosurgical review.
[53] M. Reddy,et al. Defining the Role of Stereotactic Radiosurgery Versus Microsurgery in the Treatment of Single Brain Metastases , 2000, Acta Neurochirurgica.
[54] Deric M. Park,et al. Bevacizumab used for the treatment of severe, refractory perilesional edema due to an arteriovenous malformation treated with stereotactic radiosurgery. , 2012, Journal of neurosurgery.
[55] Zbigniew Petrovich,et al. Survival and pattern of failure in brain metastasis treated with stereotactic gamma knife radiosurgery. , 2002, Journal of neurosurgery.
[56] D. Kondziolka,et al. Dose selection in stereotactic radiosurgery. , 1999, Progress in neurological surgery.
[57] L. Collette,et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] M. Lehecka,et al. Operative intervention for delayed symptomatic radionecrotic masses developing following stereotactic radiosurgery for cerebral arteriovenous malformations—case analysis and literature review , 2010, Acta Neurochirurgica.
[59] R. Wiggenraad,et al. Relationship between volume, dose and local control in stereotactic radiosurgery of brain metastasis , 2009, British journal of neurosurgery.
[60] Hiroki Shirato,et al. Stereotactic Radiosurgery Plus Whole-Brain Radiation Therapy vs Stereotactic Radiosurgery Alone for Treatment of Brain Metastases: A Randomized Controlled Trial , 2007 .
[61] Francesco Scopinaro,et al. Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery , 2014, European Journal of Nuclear Medicine and Molecular Imaging.
[62] R. Maciunas,et al. 12 Gy gamma knife radiosurgical volume is a predictor for radiation necrosis in non-AVM intracranial tumors. , 2006, International journal of radiation oncology, biology, physics.
[63] W. Friedman,et al. CAN STANDARD MAGNETIC RESONANCE IMAGING RELIABLY DISTINGUISH RECURRENT TUMOR FROM RADIATION NECROSIS AFTER RADIOSURGERY FOR BRAIN METASTASES? A RADIOGRAPHIC‐PATHOLOGICAL STUDY , 2008, Neurosurgery.
[64] K. Drummond,et al. Cerebral radiation necrosis , 2014, Asia-Pacific journal of clinical oncology.
[65] Maria Werner-Wasik,et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial , 2004, The Lancet.
[66] M. Gilbert,et al. Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. , 2011, International journal of radiation oncology, biology, physics.
[67] S. Miyatake,et al. Repeated treatments with bevacizumab for recurrent radiation necrosis in patients with malignant brain tumors: a report of 2 cases , 2011, Journal of Neuro-Oncology.
[68] F. Ducray,et al. Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis , 2011, Journal of Neurology.
[69] V. Esposito,et al. Repeated stereotactic radiosurgery for patients with progressive brain metastases , 2015, Journal of Neuro-Oncology.
[70] P. Johnstone,et al. Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases , 2016, Melanoma research.
[71] T. Yoshimine,et al. Treatment outcomes using CyberKnife for brain metastases from lung cancer , 2014, Journal of radiation research.
[72] F. Lohr,et al. Radiosurgery alone or in combination with whole-brain radiotherapy for brain metastases. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] C. McPherson,et al. Results of Contemporary Surgical Management of Radiation Necrosis using Frameless Stereotaxis and Intraoperative Magnetic Resonance Imaging , 2004, Journal of Neuro-Oncology.
[74] Y. Kajimoto,et al. Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas , 2008, Journal of Neuro-Oncology.
[75] C. Lebrun,et al. Le bévacizumab dans le traitement des radionécroses cérébrales , 2011 .
[76] E. Shaw,et al. Managing the cognitive effects of brain tumor radiation therapy , 2006, Current treatment options in oncology.
[77] L. Marucci,et al. Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease , 2013, Journal of Neuro-Oncology.
[78] Yoshiyuki Suzuki,et al. Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14) , 2013, Journal of radiation research.
[79] Yoshiyuki Suzuki,et al. Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis , 2013, Journal of radiation research.
[80] F. Dhermain,et al. Stereotactic radiation and checkpoint inhibitors in melanoma patients with BM: a question of drug, timing or both? , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[81] L. Chin,et al. Radiation necrosis following gamma knife surgery: a case-controlled comparison of treatment parameters and long-term clinical follow up. , 2001, Journal of neurosurgery.
[82] Michael Peacock,et al. Volumetric Radiosurgery for 1 to 10 Brain Metastases: A Multicenter, Single-Arm, Phase 2 Study. , 2016, International journal of radiation oncology, biology, physics.
[83] W. Friedman,et al. Linear accelerator stereotactic radiosurgery for metastatic brain tumors: 17 years of experience at the University of Florida. , 2008, Neurosurgery.
[84] K. Ahmed,et al. Fractionated stereotactic radiotherapy to the post-operative cavity for radioresistant and radiosensitive brain metastases , 2014, Journal of Neuro-Oncology.
[85] James L. Frazier,et al. Stereotactic radiosurgery in the management of brain metastases: an institutional retrospective analysis of survival. , 2010, International journal of radiation oncology, biology, physics.
[86] A. Hasso,et al. The effect of bevacizumab (Avastin) on neuroimaging of brain metastases. , 2008, Surgical neurology.
[87] J. Ruben,et al. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. , 2006, International journal of radiation oncology, biology, physics.
[88] D. Kondziolka,et al. The results of resection after stereotactic radiosurgery for brain metastases. , 2009, Journal of neurosurgery.
[89] Yoshiya Yamada,et al. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases , 2015, Journal of Neuro-Oncology.
[90] Yang Wang,et al. Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients , 2012, European Journal of Medical Research.
[91] K. Hess,et al. Reoperation for recurrent metastatic brain tumors. , 1995, Journal of neurosurgery.
[92] M. Mut. Surgical treatment of brain metastasis: A review , 2012, Clinical Neurology and Neurosurgery.
[93] G. Gibney,et al. Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.
[94] L Souhami,et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. , 2000, International journal of radiation oncology, biology, physics.
[95] James M. Balter,et al. Imaging Changes after Stereotactic Radiosurgery of Primary and Secondary Malignant Brain Tumors , 2004, Journal of Neuro-Oncology.
[96] E. Kasper,et al. Diagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery , 2015, American Journal of Neuroradiology.
[97] K. Patel,et al. Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases , 2017, American journal of clinical oncology.
[98] A. Holodny,et al. Comparison of the effectiveness of MRI perfusion and fluorine-18 FDG PET-CT for differentiating radiation injury from viable brain tumor: a preliminary retrospective analysis with pathologic correlation in all patients. , 2013, Clinical imaging.
[99] M. McDermott,et al. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. , 2015, Journal of neurosurgery.
[100] A. Friedman,et al. Treatment of radiation‐induced nervous system injury with heparin and warfarin , 1994, Neurology.
[101] T. Mikkelsen,et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis , 2009, Journal of Neuro-Oncology.
[102] O. Belohlávek,et al. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression? , 2002, European Journal of Nuclear Medicine and Molecular Imaging.
[103] Laura W. Christianson,et al. Local control after fractionated stereotactic radiation therapy for brain metastases , 2014, Journal of Neuro-Oncology.
[104] C. Belka,et al. Prognostic factors for survival and radiation necrosis after stereotactic radiosurgery alone or in combination with whole brain radiation therapy for 1–3 cerebral metastases , 2014, Radiation oncology.
[105] E. Dropcho. Neurotoxicity of radiation therapy. , 2010, Neurologic clinics.
[106] D. Knol,et al. Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence , 2009, Journal of Neurology.